跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Salindah-B2 - NPRA Drug Approval Details
Approvals
/
NPRA
/
Salindah-B2
Approved
STANDARD
Salindah-B2
DARULAMAN MANUFACTURING SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
3d7589ee2a48ef5a
Company
DARULAMAN MANUFACTURING SDN. BHD.
Type
Standard
Approval Details
Approval Id
3d7589ee2a48ef5a
Drug Approval Npra Name
Salindah-B2
Product Name
Salindah-B2
Registration Number
MAL05092336T
Holder Company Name
DARULAMAN MANUFACTURING SDN. BHD.
Holder Address
LOT 59, 60, 61 & 62 TAMAN INDUSTRI KEDA NAPOH 06000 JITRA MALAYSIA
Holder Phone
04-9161767
Manufacturer Company Name
DARULAMAN MANUFACTURING SDN. BHD.
Manufacturer Address
LOT 59, 60, 61 & 62 TAMAN INDUSTRI KEDA NAPOH 06000 JITRA MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL05092336T
Version
1751614170
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
3d7589ee2a48ef5a
Type
Standard
Source
Official Source
Back to NPRA Approvals